Clinical Pharmacology Flashcards
Acute intermittent porphyria
What drugs may precipitate attack?
AIP is caused by defect in porphobilinogen deaminase
Drugs which may precipitate attack in AIP
* barbiturates
* halothane
* benzodiazepines
* alcohol
* oral contraceptive pill
* sulphonamides
What is the effect of adrenaline?
Sympathomimetic amine - has both alpha + beta adernergic stim properties
- Causes vasodilation
- Increases vasoconstriction in skin + skidneys
- Increases cardiac output and total peripheral resistance
Alpha adrenergic receptors
* Inhibits insulin secretion by pancreas
* Stimulates glycogenolysis in liver and muscle
Beta adrenergic receptors
* Stimulates glucagon secretion in pancrease
* Stimulates ACTH
* Stimulates lipolysis by adipose tissue
Give an example of beta1 and beta2 agonists
Beta-1 agonists
dobutamine
Beta-2 agonists
salbutamol
Give an example of alpha 1 and 2 agonists
Alpha-1 agonists
phenylephrine
Alpha-2 agonists
clonidine
Adrenoreceptor antagonists
Alpha-1 antagonist
Alpha-1a antagonist
Alpha-2 antagonist
Alpha antagonists
alpha-1: doxazosin
alpha-1a: tamsulosin - acts mainly on urogenital tract
alpha-2: yohimbine
Name a beta-1 antagonist and non-selective antagonist
Beta antagonists
beta-1: atenolol
non-selective: propranolol
Allopurinol interactions
- Azathioprine
- Cyclophosphamide - reduced renal clearance, marrow toxicity
- Theophylline - increase plasma concentration
Describe the mechanism by which amiodarone causes hypothyroidism
The pathophysiology of amiodarone-induced hypothyroidism (AIH) is thought to be due to the high iodine content of amiodarone causing a Wolff-Chaikoff effect*
*an autoregulatory phenomenon where thyroxine formation is inhibited due to high levels of circulating iodide
Beta-blocker overdose
Features
Management
Features
* bradycardia
* hypotension
* heart failure
* syncope
Management
* if bradycardic then atropine
* in resistant cases glucagon may be used
Haemodialysis is not effective in beta-blocker overdose
Ciclosporin
nephrotoxicity
hepatotoxicity
fluid retention
hypertension
hyperkalaemia
hypertrichosis
gingival hyperplasia
tremor
impaired glucose tolerance
hyperlipidaemia
increased susceptibility to severe infection
Digoxin
MOA
Mechanism of action
* decreases conduction through the atrioventricular node which slows the ventricular rate in atrial fibrillation and flutter
* increases the force of cardiac muscle contraction due to inhibition of the Na+/K+ ATPase pump. Also stimulates vagus nerve
* digoxin has a narrow therapeutic index
Digoxin toxicity
Features
Features
* generally unwell, lethargy, nausea & vomiting, anorexia, confusion, yellow-green vision
* arrhythmias (e.g. AV block, bradycardia)
* gynaecomastia
Why is hypokalaemia a precipitating factor of digoxin toxicity
digoxin normally binds to the ATPase pump on the same site as potassium. Hypokalaemia → digoxin more easily bind to the ATPase pump → increased inhibitory effects
Management of digoxin toxicity
Management
Digibind
correct arrhythmias
monitor potassium
Drugs that cause impaired glucose tolerance
thiazides, furosemide (less common)
steroids
tacrolimus, ciclosporin
interferon-alpha
nicotinic acid
antipsychotics
Drug induced thrombocytopenia
quinine
abciximab
NSAIDs
diuretics: furosemide
antibiotics: penicillins, sulphonamides, rifampicin
anticonvulsants: carbamazepine, valproate
heparin
Drugs that cause urinary retention
tricyclic antidepressants e.g. amitriptyline
anticholinergics e.g. antipsychotics, antihistamines
opioids
NSAIDs
disopyramide
Side effects of sulfonylureas
Hypoglycaemic episodes
Increased appetite and weight gain
Syndrome of inappropriate ADH secretion
Liver dysfunction (cholestatic)
Side effects of glitazones
Weight gain
Fluid retention
Liver dysfunction
Fractures
Sife effects of isioniazid
mechanism of action: inhibits mycolic acid synthesis
peripheral neuropathy: prevent with pyridoxine (Vitamin B6)
hepatitis, agranulocytosis
liver enzyme inhibitor
Side effects of pyrazinamide
mechanism of action: converted by pyrazinamidase into pyrazinoic acid which in turn inhibits fatty acid synthase (FAS) I
hyperuricaemia causing gout
arthralgia, myalgia
hepatitis
Ethambutol
Side effect
MOA
mechanism of action: inhibits the enzyme arabinosyl transferase which polymerizes arabinose into arabinan
optic neuritis: check visual acuity before and during treatment
dose needs adjusting in patients with renal impairment
Cellular targets of drugs
Name 4 main types of cellular targets
- Ligand gated Ion channels
- G-protein coupled receptors
- Tyrosine kinase receptors
- Nuclear receptors
Ligand gated ion channel
Ion channel coupled to a membrane receptor causing direct signalling
Nicotinic acetylcholine receptor
GABA receptor
GPCR
MOA
Eg
- Drug binds to target that causes a sequence of events that leads to indirect signalling cAMP»_space;
- Second messengers cause the effect
- Adrenoreceptors
Tyrosine kinase receptors
MOA
Eg
- When drug activates TKR, leads to phosphorylation that causes cell growth and differentiation
- Insulin
Nuclear receptors
- Receptors located on nucleus of cell and activation or inhibition of receptors via decreased/increased gene transcription
- Lipid-soluble drugs can only work as they need to penetrate cell membrane to get to nucleus
- After penetration, the drug can form complex with receptor protein
- Levothyroxine, steroid, spironolactone, oestrogen
Drugs that cause photosensitivity
Causes of drug-induced photosensitivity
thiazides
tetracyclines, sulphonamides, ciprofloxacin
amiodarone
NSAIDs e.g. piroxicam
psoralens
sulphonylureas
Antibiotics
Name bactericidal antibiotic
penicillins
cephalosporins
aminoglycosides
nitrofurantoin
metronidazole
quinolones
rifampicin
isoniazid
Bacteriostatic antibiotics
Name 5
chloramphenicol
macrolides
tetracyclines
sulphonamides
trimethoprim
HIV drugs
What is the mOA of enfuvirtide and maraviroc
Entry inhibitors that prevent HIV-1 from entering and infecting immune cells
HIV management
Name some NRTIs
- Zidovudine
- Abacavir
- Emtricitabine
- Didanosine
- Lamivudine
- Stavudine
- Zalcitabine
- Tenofovir
What is a general side effect of NRTI?
Describe side effects
Tenofovir
Zidovudine
Didanosine
- General side effects NRTI - peripheral neuropathy
- Tenofovir - renal impairment osteoporosis
- Zidovudine: anaemia, myopathy, black nails
- Didanosine: pancreatitis
NNRTI
Give 2 examples
Give 3 general SE
Non-nucleoside reverse transcriptase inhibitors (NNRTI)
examples: nevirapine, efavirenz
side-effects: P450 enzyme interaction (nevirapine induces), rashes
What is the MOA of the following drugs
Indinavir, nelfinavir, ritonavir, saquinavir
Side effects
- Protease inhibitors
- indinavir, nelfinavir, ritonavir, saquinavir
- SE: diabetes, cushingoid
What is the MOA of raltegravir, elvitegravir, dolutegravir
Integrase inhibitors
* block the action of integrase, a viral enzyme that inserts the viral genome into the DNA of the host cell
* examples: raltegravir, elvitegravir, dolutegravir
Drugs in managing LUTS
Predominantly voiding symptoms - ‘poor stream’, what drugs are indicated?
- if ‘moderate’ or ‘severe’ symptoms offer an alpha-blocker
- if the prostate is enlarged and the patient is ‘considered at high risk of progression’ then a 5-alpha reductase inhibitor should be offered
Drugs in managing LUTS
Predominantly overactive bladder
- antimuscarinic drugs should be offered if symptoms persist. NICE recommend oxybutynin (immediate release), tolterodine (immediate release), or darifenacin (once daily preparation)
- Mirabregron
What do you give if a patient presented with mixed overactive and voiding symptoms
if there are mixed symptoms of voiding and storage not responding to an alpha blocker then a antimuscarinic (anticholinergic) drug may be added